Rowland Charles A Jr bought VKTX
October 27, 2025 · Form 4 insider transaction
Rowland Charles A Jr bought 16,000 shares of Viking Therapeutics, Inc. at $4.48 per share, a transaction worth $71.7K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
16,000
Price
$4.48
Total value
$71.7K
InsiderRowland Charles A Jr
RoleDirector
SecurityCommon Stock, par value $0.00001 per share
Transaction codeA: Grant or award
Transaction dateOctober 27, 2025
Filing dateOctober 28, 2025
Shares owned after46,000
OwnershipDirect
10b5-1 planNo
AmendedNo